• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Ancom Anti-Hypertensive Compound Tablets

Audience: Pharmacists, other healthcare professionals, and consumers

[January 17, 2003] Herbsland Inc. recalled all 100 tablet bottles of Ancom Anti-Hypertensive Compound Tablets, an unapproved new drug labeled to contain several prescription drug ingredients, including reserpine, diazepam, promethiazine, and hydrochlorothiazide. The sale of a product with this combination of ingredients poses possible serious health risks including sedation, depression, and potentially life-threatening abnormalities of the blood. This recall includes all lot codes of the product remaining on the market. Ancom Tablets were sold without prescriptions to consumers through distributors and retail stores located in the New York City metropolitan area, specifically Manhattan, Brooklyn, and Queens. Nationwide sales are also possible as this product was sold via the Internet.

[UPDATE March 18, 2003] Ancom Tablets were sold without prescriptions to consumers at Tai Chien's retail establishment in New York City. Product was also sold to a distributor in Puerto Rico. At least one illness has been reported to date.

[March 18, 2003 - Press Release - Tai Chien Inc.]
[January 17, 2003 - Press Release - Herbsland, Inc.]